WJPR Citation New

  All Since 2019
 Citation  7475  4312
 h-index  28  21
 i10-index  197  83

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

COMPUTATIONAL INSIGHTS INTO SULFONYLUREA CONTAINING ANTIDIABETIC DRUGS TARGETING PPAR-γ: A COMPREHENSIVE REVIEW

Shubham N. Karle* and Dr. Megha T. Salve

.

Abstract

Diabetes mellitus is a global health concern characterized by impaired insulin function or production, leading to elevated blood glucose levels. SU-containing antidiabetic drugs have long been utilized in the management of type 2 diabetes mellitus. Their mechanism of action primarily involves the stimulation of insulin secretion from pancreatic β-cells. In recent years, the role of PPAR-γ in glucose and lipid metabolism has gained significant attention. This comprehensive review explores the molecular interactions between SU drugs and PPAR-γ through computational methods, shedding light on their potential significance in diabetes treatment. This comprehensive review provides a detailed exploration of Binding affinity to the receptor, Toxicity, Pharmacokinetic, Pharmacodynamic properties such as BBB permeation, HIA, P-glycoprotein substrate, cytochrome P450 isoform inhibition, Log Kp, and bioavailability ranking etc. of SU-based antidiabetic drugs and their ability to produce agonist effect on PPAR isoforms (PPAR-γ) by using various in silico evaluation software’s like Molinspiration, ADMETlab 2.0, ProTox-II, 1-Click Docking, ChemSketch, SwissADME etc. A major focus of this review is the utilization of computational techniques and tools to rationalize the design of PPAR-γ agonists. Utilizing in silico techniques, potential agonistic effects on PPAR- γ have been uncovered, focusing on the examination of six commercially available anti-diabetic agents. The study pinpointed PPAR- γ a protein targets (1i7i). Further investigation is advised to explore the potential of these marketed anti-diabetic agents to evolve into a safe and scientifically substantiated multi-target drug for diabetes treatments.

Keywords: Computer-aided method, Sulfonylurea-containing antidiabetic drugs, Pharmacokinetics, Peroxisome Proliferator-Activated Receptor-? (1i7i), Toxicity Profile.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More